Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers

Sexually Transmitted Diseases

Volumn 40, Issue 5, 2013, Pages 401-405

  Gerend, Mary A ^a   Shepherd, Melissa A ^b   Lustria, Mia Liza A ^b  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; BEHAVIOR; COST; FEMALE; HUMAN; OUTCOME VARIABLE; PATIENT SAFETY; PREDICTOR VARIABLE; SEXUAL BEHAVIOR; SOCIAL PSYCHOLOGY;

ADOLESCENT; DECISION MAKING; DELIVERY OF HEALTH CARE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MOTIVATION; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUAL BEHAVIOR; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84876287988     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318283c8a8     Document Type: Article

References (28)

1. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-24.
2. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626-629.
3. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 yearsV United States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59: 1018-1023.
4. Centers for Disease Control and Prevention. Adult vaccination coverageVUnited States, 2010. MMWR Morb Mortal Wkly Rep 2012; 61:66-72.
5. Niccolai LM, Mehta NR, Hadler JL. Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med 2011; 41:428-433.
6. Davis K, Dickman ED, Ferris D, et al. Human papillomavirus vaccine acceptability among parents of 10-to 15-year-old adolescents. J Low Genit Tract Dis 2004; 8:188-194.
7. Dempsey AF, Zimet GD, Davis RL, et al. Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics 2006; 117:1486-1493.
8. Patel DA, Zochowski M, Peterman S, et al. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health 2012; 60:151-161.
9. Reiter PL, Stubbs B, Panozzo CA, et al. HPV and HPV vaccine education intervention: Effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev 2011; 20:2354-2361.
10. Gillespie L, Hicks CW, Santana M, et al. The acceptability of human papillomavirus vaccine among parents and guardians of newborn to 10-year-old children. J Pediatr Adolesc Gynecol 2011; 24:66-70.
11. Bettinghaus EP. Health promotion and the knowledge-attitude-behavior continuum. Prev Med 1986; 15:475-491.
12. Kreuter MW, Wray RJ. Tailored and targeted health communication: Strategies for enhancing information relevance. Am J Health Behav 2003; 27(suppl 3):S227-S232.
13. Noar SM, Benac CN, Harris MS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bul 2007; 133:673-693.
14. Portnoy DB, Scott-Sheldon LAJ, Johnson BT, et al. Computer-delivered interventions for health promotion and behavioral risk reduction: A meta-analysis of 75 randomized controlled trials, 1988-2007. Prev Med 2008; 47:3-16.
15. Krebs P, Prochaska JO, Rossi JS. A meta-analysis of computer-tailored interventions for health behavior change. Prev Med 2010; 51:214-221.
16. Lustria MLA, Noar SM, Cortese J, et al. A meta-analysis of web-delivered, tailored health behavior change interventions. J Health Comm. In press.
17. Janz NK, Becker MH. The Health Belief Model: A decade later. Health Educ Q 1984; 11:1-47.
18. Allen JD, Mohllajee AP, Shelton RC, et al. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2009; 48:420-425.
19. Brewer NT, Gottlieb SL, Reiter PL, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 2011; 38:197-204.
20. Gerend MA, Shepherd JE. Predicting human papillomavirus vaccine uptake in young adult women: Comparing the Health Belief Model and Theory of Planned Behavior. Ann Behav Med 2012; 44:171-180.
21. Reiter PL, Brewer NT, Gottlieb SL, et al. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009; 69:475-480.
22. Gerend MA, Shepherd MA, Shepherd JE. The multidimensional nature of perceived barriers: Global versus practical barriers to HPV vaccination. Health Psychol 2011: Advance online publication.
23. Gerend MA, Shepherd JE. Correlates of HPV knowledge in the era of HPV vaccination: A study of unvaccinated young adult women. Women Health 2011; 51:25-40.
24. Gerend MA, Shepherd JE. Using message framing to promote acceptance of the human papillomavirus vaccine. Health Psychol 2007; 26:745-752.
25. Gerend MA, Shepherd JE, Monday KA. Behavioral frequency moderates the effects of message framing on HPV vaccine acceptability. Ann Behav Med 2008; 35:221-229.
26. Lustria MLA, Cortese J, Noar SM, et al. Computer-tailored health interventions delivered over the web: Review and analysis of key components. Patient Educ Couns 2009; 74:156-173.
27. Hopfer S, Clippard JR. College women's HPV vaccine decision narratives. Qual Health Res 2011; 21:262-277.
28. Hawkins RP, Kreuter M, Resnicow K, et al. Understanding tailoring in communicating about health. Health Educ Res 2008; 23:454-466.